Computational tool helps scientists create novel bug sprays
Vector-borne pathogens, or microorganisms carried by insects such as mosquitoes and ticks, lead to 17% of all infectious disease worldwide. Transmission of these diseases to humans and animals can be mitigated through the application of compounds, commonly known as bug spray, that disrupt an insect’s sense of smell, a phenomenon known as anosmia. Such compounds confuse and block the detection of the host animal. Climate change is expanding mosquito habitats, thus leading to greater pathogen transmission, signifying a global health threat.
For the past 80 years, DEET, or diethyltoluamide, has dominated the market for insect repellents. Using single compounds for pest repellent can be dangerous because pathogens can develop resistance to the substance. Moreover, with lifestyles moving toward health and sustainability, more people are opting for herbal and natural alternatives instead of synthetic compounds. Identifying natural volatile compounds, or molecules in gas form at room temperature, offers an improvement to current repellents, since skin application is not needed, and natural compounds can be better for health and the environment. However, the discovery processes to generate these molecules are expensive and time-consuming.

Kostas Iatrou, an emeritus research director of the Institute of Biology at the National Center for Scientific Research Demokritos, Greece, and Spyros Zographos, a research director of the Institute of Chemical Biology at the National Hellenic Research Foundation, created a method to identify naturally occurring insect repellents. In a recent paper in the Journal of Biological Chemistry, Georgia Kythreoti and colleagues described a pharmacophore-based screening platform to identify natural compounds that bind mosquito olfactory receptors and cause anosmia.
By scanning hundreds of compounds computationally, the researchers narrowed down their best binders for testing in cells. Specifically, they analyzed how well the odorous ligands interact with a conserved obligatory 7-transmembrane receptor subunit, or ORco, that heteromerizes with odorant recognizing subunits, or ORx, to form olfactory receptors in most mosquitoes.
“The mosquito olfactory system is a bit of a complicated mechanism of signal transduction,” Kythreoti said. The odorous compound must first bind to an odorant-binding protein to interact with the specific receptor(s).
“(The odorant-binding protein) has to capture, solubilize and transfer the odor to the specific receptor heteromer, so this is a very important component,” Zographos said.
Despite their importance, these odorant-binding proteins often differ between insect species. Using the highly conserved ORco receptor in the pharmacophore model offered an improved approach for screening that can identify repellents widely applicable to mosquitoes and a broad range of other insect species important to health and agriculture. The authors validated their model using a collection of olfaction-relevant volatile compounds, including isopropyl cinnamate and linalyl acetate, two known ORco antagonists.
To test the binders generated by the model, researchers inserted a gloved hand into a mesh cage containing hundreds of lab-reared mosquitoes. The glove had an opening, which was surrounded by filter paper loaded with the test compound. For each trial, the team recorded the number of mosquito landings, an indicator of repellency.
“There is no magical computational tool that can do without the experimental data,” Zographos said. “You need to have good experimental data to train your models in order to go ahead with bigger data sets.”
The researchers will improve the specificity of the model by incorporating different types of data, such as additional structural and 3D data for the binding site, to give rise to rationale design of functional binders.
They hope that their pipeline will accelerate screening for new, functional binders, and their future directions will focus on identifying novel repellent compounds.
“Regardless of a final product or application, as scientists conducting basic research, we aim to contribute knowledge about the mechanisms of insect olfaction to the scientific community,” Zographos said.
Iatrou added: “We provide the tools, and it’s up to other scientists to follow up and develop additional tools that may help to discover new compounds.”
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Training AI to uncover novel antimicrobials
Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.

AI-designed biomarker improves malaria diagnostics
Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.

Matrix metalloproteinase inhibitor reduces cancer invasion
Scientists at the Mayo Clinic engineered a TIMP-1 protein variant that selectively inhibits MMP-9 and reduces invasion of triple-negative breast cancer cells, offering a promising tool for targeted cancer research.

Antibiotic sensor directly binds drug in resistant bacteria
Researchers at Drexel University uncover how the vancomycin-resistant bacterial sensor binds to the antibiotic, offering insights to guide inhibitor design that restores antibiotic effectiveness against hospital-acquired infections.

ApoA1 reduce atherosclerotic plaques via cell death pathway
Researchers show that ApoA1, a key HDL protein, helps reduce plaque and necrotic core formation in atherosclerosis by modulating Bim-driven macrophage death. The findings reveal new insights into how ApoA1 protects against heart disease.

Omega-3 lowers inflammation, blood pressure in obese adults
A randomized study shows omega-3 supplements reduce proinflammatory chemokines and lower blood pressure in obese adults, furthering the understanding of how to modulate cardiovascular disease risk.